LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 10 of 15: Cell count and normalized growth rate inhibition values within biological replicate 3. - Dataset (ID:20247)

Filter results: >>>>
Cell Small Molecule Small Mol Concentration Small Mol Conc Unit LJP Library Plate Replicate Assay Well Timepoint Timepoint Unit Total Cell Count Before Treatment Total Cell Count After Treatment Total Control Cell Count Relative Cell Count Normalized Growth Rate Inhibition Value
MCF 10A GSK1059615
1.11
uM
LJP6
3
C03
72
hr
962 1845 10641 0.1734 0.2066
MCF 10A GSK1059615
1.11
uM
LJP5
1
E03
72
hr
962 1311 10714 0.1224 0.0931
MCF 10A GSK1059615
1.11
uM
LJP5
2
E03
72
hr
962 1412 10507 0.1344 0.1176
MCF 10A GSK1059615
1.11
uM
LJP5
3
E03
72
hr
962 1562 10315 0.1514 0.1521
MCF 10A GSK1059615
3.33
uM
LJP6
1
C02
72
hr
962 621 10693 0.0581 -0.1184
MCF 10A GSK1059615
3.33
uM
LJP6
2
C02
72
hr
962 769 10740 0.0716 -0.0624
MCF 10A GSK1059615
3.33
uM
LJP6
3
C02
72
hr
962 845 10641 0.0794 -0.0368
MCF 10A GSK1059615
3.33
uM
LJP5
1
E02
72
hr
962 696 10714 0.0650 -0.0889
MCF 10A GSK1059615
3.33
uM
LJP5
2
E02
72
hr
962 801 10507 0.0762 -0.0518
MCF 10A GSK1059615
3.33
uM
LJP5
3
E02
72
hr
962 921 10315 0.0893 -0.0127
MCF 10A GSK1059615
10
uM
LJP6
1
C01
72
hr
962 429 10693 0.0401 -0.2074
MCF 10A GSK1059615
10
uM
LJP6
2
C01
72
hr
962 521 10740 0.0485 -0.1616
MCF 10A GSK1059615
10
uM
LJP6
3
C01
72
hr
962 525 10641 0.0493 -0.1603
MCF 10A GSK1059615
10
uM
LJP5
1
E01
72
hr
962 454 10714 0.0424 -0.1943
MCF 10A GSK1059615
10
uM
LJP5
2
E01
72
hr
962 465 10507 0.0443 -0.1901
MCF 10A GSK1059615
10
uM
LJP5
3
E01
72
hr
962 521 10315 0.0505 -0.1641
MCF 10A Brivanib
0.04
uM
LJP5
1
P18
72
hr
962 10632 10714 0.9924 0.9956
MCF 10A Brivanib
0.04
uM
LJP5
2
P18
72
hr
962 10454 10507 0.9949 0.9970
MCF 10A Brivanib
0.04
uM
LJP5
3
P18
72
hr
962 10559 10315 1.0236 1.0137
MCF 10A Brivanib
0.12
uM
LJP5
1
P17
72
hr
962 10457 10714 0.9760 0.9861
MCF 10A Brivanib
0.12
uM
LJP5
2
P17
72
hr
962 10461 10507 0.9955 0.9974
MCF 10A Brivanib
0.12
uM
LJP5
3
P17
72
hr
962 10601 10315 1.0277 1.0160
MCF 10A Brivanib
0.37
uM
LJP5
1
P16
72
hr
962 10105 10714 0.9432 0.9666
MCF 10A Brivanib
0.37
uM
LJP5
2
P16
72
hr
962 9964 10507 0.9482 0.9694
MCF 10A Brivanib
0.37
uM
LJP5
3
P16
72
hr
962 10266 10315 0.9952 0.9972